News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Alzheimer’s still waiting for affordable treatment

PRESS RELEASE

People with Alzheimer’s still waiting for affordable treatment

People with Alzheimer’s disease are currently denied the right to accessible and affordable anti-Alzheimer’s medications, which can delay the progression of this form of dementia. These drugs are not subsidised and cost from $200 to $250 a month. The lack of government funding for dementia treatment means greater health inequalities are being created between the wealthy and the poor because access to treatment depends on one’s ability to pay.

Last year Pharmac agreed to consider a way of making the drugs available to at least some patients as there are currently no subsidised pharmaceuticals for Alzheimer’s disease and other dementias, but there has been no action to date.

Today Pharmac announced a $50 million increase in its annual funding from the government budget. Pharmac also underspent by $24million in 2002.

“ We need these medications subsidised without further delay” said Karen Hyland, Director of Alzheimers New Zealand.

“Many younger people are being diagnosed with Alzheimer’s disease. With the ability to diagnose earlier there is a responsibility to ensure that treatment to minimise the effect of the disease can be accessed,” said Karen Hyland.

“Precious time with families can be lengthened and admissions to rest homes can be delayed with these medications, so it is unbelievable that this treatment is not given any health funding priority”, said Karen Hyland.

“In recent years early diagnosis techniques have been advanced. But what is the point of being able to diagnose early if the treatment remains unavailable. We must ensure that everyone with Alzheimer’s disease can access these medications”.

“All Alzheimers New Zealand asks is that people with Alzheimer’s disease are afforded the same respect and priority that others with medical diseases are. We must ensure that people can sort out their lives before they can no longer do so by buying time with these medications. Families who are already trying to cope with the high cost of this disease are at a huge disadvantage,” said Karen Hyland.


ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

ALSO:

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

Negotiations Begin: Equal Conditions For Men & Women In Professional Football

The trade union representing New Zealand's professional footballers has initiated bargaining for an agreement securing equal terms and conditions for men and women. If negotiated, it will be the first agreement of its kind in the world. More>>

ALSO:


New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>

ALSO:


Howard Davis Review: Conflict & Resistance - Ria Hall's Rules of Engagement

From the aftermath of war through colonisation to her own personal convictions, Hall's new CD addresses current issues and social problems on multiple levels, confirming her position as a polemical and preeminent voice on the indigenous NZ music scene. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland